EmeraNova™ Adds Hyaluronic Acid Matrix Technology, Supporting Expansion to New Care Settings

PHOENIX–(BUSINESS WIRE)–EmeraNovaTM, the new corporate identity of BioLab Holdings and a medical technology company building an advanced tissue restoration platform, is expanding its tissue preparation and restorative capabilities through a new commercialization collaboration with Hyalomatrix®.Hyalomatrix is a regenerative matrix built on hyaluronic acid technology to support tissue regeneration and complex wound healing. The technology joins EmeraNova’s growing toolbox of solutions designed t

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.